Dr. Sanket S. Mehta

Dr. Sanket S. Mehta
Surgical Oncologist, Mumbai

MBBS, MS, DNB, FCPS

  • 5 Hospitals
  • Dr. Sanket S. Mehta is a Consultant at Criticare Multispeciality Hospital & Research Centre, Saifee Hospital, Bombay Hospital And Medical Research Center, Dr. L H Hiranandani Hospital, Haria L G Rotary Hospital, Mumbai
  • Dr. Sanket Mehta is the first surgeon in India to treat peritoneal malignancies with Cytoreductive surgery and Hyperthermic Intra-peritoneal Chemotherapy using an advanced HIPEC system
  • Dr. Sanket S. Mehta is a specialises in Minimal Access (Laparoscopic) surgery for colo-rectal, urologic and gynaecologic malignancies

Specialities

  • Surgical Oncology

Procedures

  • Chemotherapy

Expertise

  • Cytoreductive surgery (CRS) and Hyperthermic Intra-peritoneal chemotherapy (HIPEC)
  • Laparoscopisc Gastro-intestinal and Gynaecologic Oncosurgery

Education

  • MBBS from Lokmanaya Tilak Municipal Medical College, Mumbai
  • MS (General Surgery) from Lokmanaya Tilak Municipal Medical College, Mumbai
  • DNB
  • Surgical training in LTMGH college (Sion, Mumbai)
  • Basic oncosurgery training from Tata Memorial Hospital
  • Clinical Fellow Laparoscopic and Robotic Colorectal surgery department, St. Mary's Hospital, Seoul, S. Korea.
  • Clinical Fellow Digestive Oncology, CRLC Val d'Aurelle, Montellier, France
  • Rotary Ambassadorial Scholar year 2009-2010
  • Specialist Registrar GI and Thoracic Oncology, Tata Memorial Hospital for the year 2009

Practice Information

Criticare Multispeciality Hospital & Research Centre, Mumbai

Criticare Multispeciality Hospital & Research Centre, Mumbai

JVPD Scheme, Juhu, Main Gulmohar Road, Andheri (W), Mumbai, Maharashtra - 400049

Saifee Hospital, Mumbai

Saifee Hospital, Mumbai

15/17, Maharshi Karve Marg, Girgaon, Mumbai, Maharashtra - 400004

Bombay Hospital And Medical Research Center, Mumbai

Bombay Hospital And Medical Research Center, Mumbai

12, Marine Lines, , Marine Lines, Mumbai, Maharashtra - 400020

Dr. L H Hiranandani Hospital, Mumbai

Dr. L H Hiranandani Hospital, Mumbai

Hill Side Avenue, Hiranandani Gardens, Powai, Mumbai, Maharashtra - 400076

Haria L G Rotary Hospital, Vapi

Haria L G Rotary Hospital, Vapi

Plot No. 363/1 & 364, Housing Sector, GIDC, Vapi, Gujarat - 396195

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Sanket S. Mehta and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Research & PublicationsJoshi RM, Palep JH, Sayed S, Mehta S. Hepatic resection: An insight. Indian J Surg 2005;67:13-20 
  • Mistry RC, Mehta SS, Karimundackal G, Pramesh CS. Novel cost-effective method of laparoscopic feeding-jejunostomy. J Minim Access Surg 2009;5(2):43-6 
  • Vijayabhaskar R, Mehta SS, Deodhar KK, Pramesh CS, Mistry RC. PEComa of the lung. J Cancer Res Ther. 2010 Jan-Mar;6(1):109-11 
  • Quenet F, Goere D, Mehta SS, Roca L, Mehdi H, Saint-Aubert B, Elias D. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC following cytoreductive surgery for colorectal carcinomatosis. Annals of Surgery. 254(2):294-301, August 2011 
  • Mehta SS, Doumaine G, Mura T, Nocca D, Fabre JM. Laparoscopic versus open distal pancreatectomy – A mono-institutional case-control study. Surg Endosc Volume 26, Issue 2(2012), Page 402-407
  • Mehta SS, Colombo PE, Quenet F, Mura T, Doumaine G, Rouanet P, Fabre JM. Spleen and Splenic vessel conservation strategy during distal pancreatic resections - A bi-institutional study of 128 patients. (Under review)
  • Recipient of the prestigious Rotary International Ambassadorial Scholarship for the year in 2009 - 2010
  • 2nd Prize in the Best paper presentation category in MASICON 2000
  • First Indian surgeon to make a presentation in ASCO-GI meet on Cytoreductive surgery and HIPEC for colorectal carcinomatosis
  • First surgeon to perform Cytoreductive surgery and HIPEC using the advanced HIPEC system in the country
  • Oral Communication, 6ème Congrès Francophone de Chirurgie Digestive et Hépato-Biliaire, December 2010. Chimiohyperthermie intra péritonéale par oxaliplatine ou oxali-irinotecan après cytoréduction complète de la carcinose péritonéale d’origine colo-rectale. Etude prospective bicentrique à propos de 146 patients 
  • Oral Communication, ESSO 2010 – 15th Congress of the European Society of Surgical Oncology, Bordeaux. Carcinologic Resection of Abdominal Tumors Involving Retroperitoneal Vessels: Results of a Synergical Multidisciplinary Approach between Oncological and Vascular Surgical Teams 
  • Poster presentation and communication, ASCO 2011, San Francisco, Gastrointestinal Cancers Symposium - Category: Cancers of the Colon and Rectum - Multidisciplinary Treatment - Two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC following complete cytoreductive surgery for colorectal carcinomatosis 
  • Poster presentation, EHPBA 2005 - Heidelburg “Complications following Pancreato-biliary surgery- An Audit” 
  • Paper presentation, 26th Annual conference - MASICON 2004 in the ‘Best paper presentation’ category entitled “A Prospective study of 180 consecutive cases of Head injury in a major trauma centre in Mumbai” 
  • Won third prize in best paper presentation category at The 26th Annual conference- MASICON 2004 
  • Video presentation, MASICON 2012, Principles of Cytoreductive Surgeryand Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) for peritoneal malignancies 
  • Poster presentation, MASICON 2012, Cytoreductive Surgery (CRS) and Hyerthermic, Intra-Peritoneal Chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis